Verfahren zur Behandlung von resistenten Glioblastomen

Procédé de traitement de glioblastome résistant

Method for treating resistant glioblastoma

Abstract

The present invention relates to a compound which is an antagonist of β8 integrin or an inhibitor of the expression of β8 integrin for use in the treatment of resistant glioblastoma.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (63)

    Publication numberPublication dateAssigneeTitle
    WO-0136646-A1May 25, 2001Cancer Research Ventures LimitedInhibition d"expression genique a l"aide d"arn bicatenaire
    US-5696157-ADecember 09, 1997Molecular Probes, Inc.Sulfonated derivatives of 7-aminocoumarin
    US-6048616-AApril 11, 2000Philips Electronics N.A. Corp.Encapsulated quantum sized doped semiconductor particles and method of manufacturing same
    US-6573099-B2June 03, 2003Benitec Australia, Ltd.Genetic constructs for delaying or repressing the expression of a target gene
    US-5187288-AFebruary 16, 1993Molecular Probes, Inc.Ethenyl-substituted dipyrrometheneboron difluoride dyes and their synthesis
    US-6280929-B1August 28, 2001The Regents Of The University Of CaliforniaMethod of detecting genetic translocations identified with chromosomal abnormalities
    US-5274113-ADecember 28, 1993Molecular Probes, Inc.Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
    US-6689338-B2February 10, 2004The Board Of Regents For Oklahoma State UniversityBioconjugates of nanoparticles as radiopharmaceuticals
    US-5635601-AJune 03, 1997Genentech, Inc.Beta-8 integrin subunit antibodies
    US-6207392-B1March 27, 2001The Regents Of The University Of CaliforniaSemiconductor nanocrystal probes for biological applications and process for making and using such probes
    US-5433896-AJuly 18, 1995Molecular Probes, Inc.Dibenzopyrrometheneboron difluoride dyes
    US-6306736-B1October 23, 2001The Regents Of The University Of CaliforniaProcess for forming shaped group III-V semiconductor nanocrystals, and product formed using process
    US-5800996-ASeptember 01, 1998The Perkin Elmer CorporationEnergy transfer dyes with enchanced fluorescence
    US-6649138-B2November 18, 2003Quantum Dot CorporationSurface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
    US-5830912-ANovember 03, 1998Molecular Probes, Inc.Derivatives of 6,8-difluoro-7-hydroxycoumarin
    US-4774339-ASeptember 27, 1988Molecular Probes, Inc.Chemically reactive dipyrrometheneboron difluoride dyes
    US-6225198-B1May 01, 2001The Regents Of The University Of CaliforniaProcess for forming shaped group II-VI semiconductor nanocrystals, and product formed using process
    US-5447841-ASeptember 05, 1995The Regents Of The Univ. Of CaliforniaMethods for chromosome-specific staining
    US-6855202-B2February 15, 2005The Regents Of The University Of CaliforniaShaped nanocrystal particles and methods for making the same
    US-6914256-B2July 05, 2005North Carolina State UniversityOptoelectronic devices having arrays of quantum-dot compound semiconductor superlattices therein
    US-6682596-B2January 27, 2004Quantum Dot CorporationFlow synthesis of quantum dot nanocrystals
    WO-0168836-A2September 20, 2001Genetica, Inc., Cold Spring Harbor LaboratoryMethods and compositions for rna interference
    WO-9926299-A1May 27, 1999Massachusetts Institute Of TechnologyHighly luminescent color-selective materials
    US-4888278-ADecember 19, 1989University Of Massachusetts Medical CenterIn-situ hybridization to detect nucleic acid sequences in morphologically intact cells
    US-6130101-AOctober 10, 2000Molecular Probes, Inc.Sulfonated xanthene derivatives
    US-5451663-ASeptember 19, 1995Molecular Probes, Inc.Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
    US-5472842-ADecember 05, 1995The Regents Of The University Of CaliforniaDetection of amplified or deleted chromosomal regions
    US-2007117153-A1May 24, 2007Christopher Bieniarz, Julia Ashworth-Sharpe, Kernag Casey A, Kosmeder Jerome W, Mark LefeverMolecular conjugate
    US-6500622-B2December 31, 2002Quantum Dot CorporationMethods of using semiconductor nanocrystals in bead-based nucleic acid assays
    US-5427932-AJune 27, 1995Reagents Of The University Of CaliforniaRepeat sequence chromosome specific nucleic acid probes and methods of preparing and using
    WO-2011020529-A2February 24, 2011Merck Patent GmbhAntibodies for the detection of integrin complexes in ffpe material
    US-6114038-ASeptember 05, 2000Biocrystal Ltd.Functionalized nanocrystals and their use in detection systems
    US-5132432-AJuly 21, 1992Molecular Probes, Inc.Chemically reactive pyrenyloxy sulfonic acid dyes
    US-5690807-ANovember 25, 1997Massachusetts Institute Of TechnologyMethod for producing semiconductor particles
    US-4946778-AAugust 07, 1990Genex CorporationSingle polypeptide chain binding molecules
    US-2011076283-A1March 31, 2011Universite De LausanneMethod for predicting and diagnosing brain tumor
    US-6602671-B1August 05, 2003Massachusetts Institute Of TechnologySemiconductor nanocrystals for inventory control
    US-4816397-AMarch 28, 1989Celltech, LimitedMultichain polypeptides or proteins and processes for their production
    US-2003165951-A1September 04, 2003Quantum Dot CorporationMethods of using semiconductor nanocrystals in bead-based nucleic acid assays
    US-5505928-AApril 09, 1996The Regents Of University Of CaliforniaPreparation of III-V semiconductor nanocrystals
    WO-9932619-A1July 01, 1999The Carnegie Institution Of Washington, The University Of MassachusettsGenetic inhibition by double-stranded rna
    US-6709929-B2March 23, 2004North Carolina State UniversityMethods of forming nano-scale electronic and optoelectronic devices using non-photolithographically defined nano-channel templates
    US-6716979-B2April 06, 2004Molecular Probes, Inc.Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
    US-5990479-ANovember 23, 1999Regents Of The University Of CaliforniaOrgano Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
    US-2005100976-A1May 12, 2005Christopher Bieniarz, Michael FarrellEnzyme-catalyzed metal deposition for the enhanced detection of analytes of interest
    US-6927069-B2August 09, 2005The Regents Of The University Of CaliforniaOrgano luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
    US-5262357-ANovember 16, 1993The Regents Of The University Of CaliforniaLow temperature thin films formed from nanocrystal precursors
    US-5225539-AJuly 06, 1993Medical Research CouncilRecombinant altered antibodies and methods of making altered antibodies
    US-6942970-B2September 13, 2005Zymed Laboratories, Inc.Identifying subjects suitable for topoisomerase II inhibitor treatment
    US-2006246524-A1November 02, 2006Christina Bauer, Christopher Bieniarz, Hartman Anthony LNanoparticle conjugates
    US-6506559-B1January 14, 2003Carnegie Institute Of WashingtonGenetic inhibition by double-stranded RNA
    US-5571018-ANovember 05, 1996Motorola, Inc.Arrangement for simulating indirect fire in combat training
    WO-2013026004-A2February 21, 2013The Regents Of The University Of CaliforniaAntibodies that bind integrin alpha-v beta-8
    US-5248782-ASeptember 28, 1993Molecular Probes, Inc.Long wavelength heteroaryl-substituted dipyrrometheneboron difluoride dyes
    US-6274323-B1August 14, 2001Quantum Dot CorporationMethod of detecting an analyte in a sample using semiconductor nanocrystals as a detectable label
    US-5866366-AFebruary 02, 1999Smithkline Beecham CorporationgidB
    WO-2011103490-A2August 25, 2011The Regents Of The University Of CaliforniaINTEGRIN αVβ8 NEUTRALIZING ANTIBODY
    US-5338854-AAugust 16, 1994Molecular Probes, Inc.Fluorescent fatty acids derived from dipyrrometheneboron difluoride dyes
    CA-2790488-A1August 25, 2011The Regents Of The University Of California, Stephen Nishimura, Jianlong Lou, Jody Lynn Baron, James D. MarksAnticorps neutralisant anti-integrine .alpha.v.beta.8
    US-6815064-B2November 09, 2004Quantum Dot CorporationLuminescent nanoparticles and methods for their preparation
    US-2006246523-A1November 02, 2006Christopher Bieniarz, Jennifer Wong, Mark Lefever, Kosmeder Jerome W, Julia Ashworth-Sharpe, Kernag Casey AAntibody conjugates
    US-6670113-B2December 30, 2003NanoprobesEnzymatic deposition and alteration of metals
    US-2004265922-A1December 30, 2004Ventana Medical Systems, Inc.Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences

NO-Patent Citations (23)

    Title
    BRUCHEZ ET AL., SCIENCE, vol. 281, 1998, pages 20132016
    CAMBIER ET AL., AM J PATHOL, 2005
    CAMBIER S; GLINE S; MU D; COLLINS R; ARAYA J; DOLGANOV G; EINHEBER S; BOUDREAU N; NISHIMURA SL: "Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: an angiogenic control switch", AM J PATHOL., vol. 166, no. 6, June 2005 (2005-06-01), pages 1883 - 94, XP055088666
    CHAN ET AL., SCIENCE, vol. 281, 1998, pages 2016 - 2018
    CHENG L; BAO S; RICH JN: "Potential therapeutic implications of cancer stem cells in glioblastoma", BIOCHEM PHARMACOL., vol. 80, no. 5, 10 May 2010 (2010-05-10), pages 654 - 65, XP027117551
    HELEN M. SHELDRAKE ET AL: "Strategies To Inhibit Tumor Associated Integrin Receptors: Rationale for Dual and Multi-Antagonists", JOURNAL OF MEDICINAL CHEMISTRY, vol. 57, no. 15, 14 August 2014 (2014-08-14), pages 6301 - 6315, XP055168328, ISSN: 0022-2623, DOI: 10.1021/jm5000547
    HEYDUK; HEYDUK, ANALYT. BIOCHEM., vol. 248, 1997, pages 216 - 27
    HOHEISEL, NATURE REVIEWS, GENETICS, vol. 7, 2006, pages 200 - 210
    J. BIOL. CHEM., vol. 274, 1999, pages 3315 - 22
    J. H. TCHAICHA ET AL: "Glioblastoma Angiogenesis and Tumor Cell Invasiveness Are Differentially Regulated by beta8 Integrin", CANCER RESEARCH, vol. 71, no. 20, 15 October 2011 (2011-10-15), pages 6371 - 6381, XP055168239, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-11-0991
    LICHTER ET AL., PROC. NATL. ACAD. SCI., vol. 85, 1988, pages 9664 - 9668
    MINAGAWA S ET AL.: "Selective targeting of TGF-Ø activation to treat fibroinflammatory airway disease", SCI TRANSL MED., vol. 6, no. 241, 18 June 2014 (2014-06-18), pages 241RA79, XP009182474, DOI: doi:10.1126/scitranslmed.3008074
    MINAGAWA SHUNSUKE ET AL: "Selective Targeting of TGF-beta Activation to Treat Fibroinflammatory Airway Disease", SCIENCE TRANSLATION MEDICINE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 6, no. 241, 18 June 2014 (2014-06-18), pages - 14, XP009182474, ISSN: 1946-6234, DOI: 10.1126/SCITRANSLMED.3008074
    P. ROTH ET AL: "Integrin control of the transforming growth factor-beta pathway in glioblastoma", BRAIN, vol. 136, no. 2, 31 January 2013 (2013-01-31), pages 564 - 576, XP055168258, ISSN: 0006-8950, DOI: 10.1093/brain/aws351
    PINKEL ET AL., PROC. NATL. ACAD. SCI., vol. 85, 1988, pages 9138 - 9142
    PIRLKEL ET AL., PROC. NATL. ACAD. SCI., vol. 83, 1986, pages 2934 - 2938
    REYES ET AL., MOL BIOL CELL, 2013
    REYES SB1; NARAYANAN AS; LEE HS; TCHAICHA JH; ALDAPE KD; LANG FF; TOLIAS KF; MCCARTY JH: "avp8 integrin interacts with RhoGDII to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion", MOL BIOL CELL, vol. 24, no. 4, 2 January 2013 (2013-01-02), pages 474 - 82, XP055168235, DOI: doi:10.1091/mbc.E12-07-0521
    S. B. REYES ET AL: "alphavbeta8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion", MOLECULAR BIOLOGY OF THE CELL, vol. 24, no. 4, 15 February 2013 (2013-02-15), pages 474 - 482, XP055168235, ISSN: 1059-1524, DOI: 10.1091/mbc.E12-07-0521
    SHELDRAKE HM1; PATTERSON LH: "Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists", J MED CHEM., vol. 57, no. 15, 14 August 2014 (2014-08-14), pages 6301 - 15, XP055168328, DOI: doi:10.1021/jm5000547
    STUPP R ET AL.: "Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial", LANCET ONCOL., vol. 15, no. 10, 19 August 2014 (2014-08-19), pages 1100 - 8
    TANNER ET AL., AM..L. PATHOL., vol. 157, 2000, pages 1467 - 1472
    THOMAS AA1; OMURO A: "Current Role of Anti-Angiogenic Strategies for Glioblastoma", CURR TREAT OPTIONS ONCOL., 31 August 2014 (2014-08-31)

Cited By (0)

    Publication numberPublication dateAssigneeTitle